To reduce risk of patient infection, the Food and Drug Administration recommends health care facilities transition to using duodenoscopes with disposable components. FDA cites challenges in cleaning devices with fixed endcaps and high levels of contamination when reusing. More than 500,000 procedures each year use duodenoscopes to diagnose and treat issues in the pancreas and bile ducts by inserting the tube in the mouth, throat and stomach. “Duodenoscopes remain critical to life-saving care for many patients in the U.S.,” said Jeff Shuren, M.D., director of FDA’s Center for Devices and Radiological Health. “While the risk of infection from inadequate reprocessing is relatively low, we are taking action because of continuing elevated levels of contamination in duodenoscopes,” FDA also announced that it is encouraging device manufacturers to aid in the transition and increase their supplies.

Related News Articles

Headline
The Food and Drug Administration May 23 announced that Medline Industries, a firm marketing and distributing Chinese-manufactured plastic syringes within the U…
Headline
The Food and Drug Administration yesterday announced an import alert for plastic syringes manufactured by two China-based manufacturers, in addition to…
Headline
The Food and Drug Administration May 9 released final guidance clarifying the definition of “remanufacturing” for reusable medical devices needing…
Headline
U.S. health care organizations should immediately transition away from using certain unauthorized plastic syringes made in China by Jiangsu Caina Medical Co.…
Headline
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
In updated guidance for makers of medical devices labeled as sterile, the Food and Drug Administration Jan. 8 listed vaporized hydrogen peroxide as an…